BioSpace News Archive

EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of cannabis extractions and refined ingredients for the pharmaceutical, nutraceutical, therapeutical and cosmetic industries, has appointed Paulo Martins as Chief Executive Officer and Country Director of its operations in Portugal.

seqWell has announced the close of a $9M Series B financing round with the goal of rapidly expanding its portfolio of genomics products into new areas such as single-cell genomics and transcriptomics.

Swift Biosciences, Inc. (“Swift”), a leader in design and manufacturing of unique DNA and RNA library preparation and normalization kits for Next-Generation Sequencing (NGS), and MGI Tech Co., Ltd. (MGI), a subsidiary of BGI Group, today announced a co-marketing agreement for Swift’s DNA and RNA library preparation products in Europe and Asia Pacific markets.

Carevature Medical, Inc. announces a new article that has just been published at the International Journal of Spine Surgery, discussing a Modified Transforaminal Thoracic Interbody Fusion Approach.

Leading health creative agency The Bloc is proud to announce the appointment of Bernardo Romero as Chief Creative Officer.

CEFALY Technology is pleased to announce that their latest technology for the drug-free treatment of migraines, the CEFALY DUAL device, and its accessories are now available across Canada direct to consumer.

Dr. Clements joined Mirum in March 2019 and most recently served as Senior Vice President, Finance and Communications.

New tracheostomy tube improvements designed to meet patient needs

This new study data demonstrates the performance of AmpliMARK™ in hematological malignancies, and suggests that it can provide high resolution, target-rich insights for clinicians and patients to better, and less invasively, manage these diseases.

Emulate’s Duodenum Intestine-Chip provides a robust system for preclinical drug assessment of drug transport, metabolism, and drug-drug interactions in the intestine